🚀 We’re growing! Are you passionate about human pluripotent stem cells? We are looking for 1 PhD student + 1 Lab technician to join us ☀️ ior.usi.ch/institute/jobs

EACR members! Join us for an interactive workshop on scientific publishing, where expert scientific editors will guide you through the essential steps of getting your research into the academic spotlight. 📅 29 September, 14:00-15:30 CEST 🌍 Zoom us02web.zoom.us/meeting/regi...

#IORjobs Open PhD Position! Join Arianna Baggiolini @ariannabaggiolini.bsky.social ’s Lab to work on human pluripotent stem cell (hPSC)-based models of the peripheral nervous system and disease. Info and application: ior.usi.ch/events-news/...

📣 Join us! Were looking for a PhD student to join our lab and work on human pluripotent stem cell (hPSC)-based models of the peripheral nervous system and disease. Come be part of our supportive and dynamic lab family in the beautiful Bellinzona, Southern Switzerland 🇨🇭☀️⛰️ ior.usi.ch/events-news/...

PhD Student at the IOR - Institute of Oncology Research in Bellinzona, Switzerland

The Institute of Oncology Research (IOR) The IOR, affiliated with the Università della Svizzera italiana (USI), is located in a brand-new, high-tech research building that hosts more than 20 differ

ior.usi.ch

Greetings from the Institute of Oncology Research (IOR) 👋 This is our official Bluesky account — stay tuned for updates, news, and insights from the Institute. Discover more at www.ior.usi.ch

#IORnews Jonas Van Lent receives the Children's Tumor Foundation's Young Investigator Award. Congrats @jonasvanlent.bsky.social ! Read more: shorturl.at/ObLS5

Congrats to our brilliant postdoc🥳, @jonasvanlent.bsky.social, on receiving the Young Investigator Award from the Children’s Tumor Foundation! This recognition is a statement to the impact of your important research🌟!. We’re excited to follow your journey and see how you’ll advance science💪🌟

Institute of Oncology Research (IOR)@iorbellinzona.bsky.social · last yr.

#IORnews Jonas Van Lent receives the Children's Tumor Foundation's Young Investigator Award. Congrats @jonasvanlent.bsky.social ! Read more: shorturl.at/ObLS5

"Senotherapeutics Revolution: Transforming Aging and Cancer Therapy": a forum in Lugano with leading experts in biology, medicine, and pharmacology. Registration is free. @iorbellinzona.bsky.social @usi.ch @ifomresearch.bsky.social www.ibsafoundation.org/en/projects/...

Senotherapeutics Revolution Forum Lugano

This IBSA Foundation Forum will provide a dynamic platform for the presentation and discussion of pioneering research on cancer and aging. Join us in Lugano on 30th June.

ibsafoundation.org

One month left to register for the 2025 Early Career Researchers Conference! In its fifth edition, this virtual conference has become a must-attend for early career researchers to discuss critical aspects of a scientific career in cancer research. Don't miss it: eacr.org/conference/e...

Happy 10th anniversary to our colleagues at @cp-trendscancer.bsky.social 🥳 And what a great way to celebrate than with this special issue! You can't miss it!! 👏👏👏

Trends in Cancer@cp-trendscancer.bsky.social · 2y ago

We turned 10! 🥳 We're celebrating a decade of progress and the vital role of early career researchers in shaping the future of cancer research. Explore our special issue—featuring work by researchers within 6 years of independence #ecr. www.cell.com/trends/cance...

📣 #OncogenicCompetence what are the factors regulating it? Have a look at our work led by our 🌟 postdoc @lisapavinato.bsky.social 🌟 now online doi.org/10.1016/j.tr...

Lisa Pavinato@lisapavinato.bsky.social · 2y ago

❓How does a cell become malignant? 🌟Several tightly regulated factors are needed to lead the cell toward a state of ‘oncogenic competence’. 🔖In this Opinion, we highlight the most updated findings about the mechanisms behind *oncogenic competence*. ➡️https://authors.elsevier.com/c/1kW698Z12ybWbi